Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort study
The negative patient-reported effects associated with a CSD result from MCED testing were small and returned to baseline within 12 months for participants with or without a cancer diagnosis. PATHFINDER results indicate potential clinical benefit of early cancer detection and minimal patient distress associated with MCED testing.